USP 41-NF36:2018 <871> Sutures - Needle Attachment |
Recognition Number | General Plastic Surgery/General Hospital |
Recognition Date | 2019-01-14 |
Recognition List | 051 |
Recognition Number | 6-417 |
Extent | Complete standard |
Standards Orgs | USP United States Pharmacopeial Convention, Inc. http://www.usp.org/ |
STG | General Plastic Surgery/General Hospital |
FDA Tech | Maegen Colehour FDA/OMPT/CDRH/ODE/DSD/PRSB1/ 301-796-6436 maegen.colehour@fda.hhs.gov |
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
Regulation Number | Device Name | Device Class | Product Code |
§878.5035 | Suture, Surgical, Nonabsorbable, Expanded, Polytetraflouroethylene | Class 2 | NBY |
§878.5030 | Suture, Nonabsorbable, Silk | Class 2 | GAP |
§878.5020 | Suture, Nonabsorbable, Synthetic, Polyamide | Class 2 | GAR |
§878.5010 | Suture, Nonabsorbable, Synthetic, Polypropylene | Class 2 | GAW |
§878.5010 | Suture, Surgical, Nonabsorbable, Poly (Vinylidene Fluoride) | Class 2 | MXW |
§878.5000 | Suture, Nonabsorbable, Synthetic, Polyester | Class 2 | GAS |
§878.5000 | Suture, Nonabsorbable, Synthetic, Polyethylene | Class 2 | GAT |
§878.4840 | Suture, Surgical, Absorbable, Polydioxanone | Class 2 | NEW |
§878.4830 | Suture, Absorbable, Natural | Class 2 | GAL |
§878.4495 | Suture, Nonabsorbable, Nitinol | Class 2 | NJU |
§878.4495 | Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile | Class 2 | GAQ |
§878.4494 | Suture, Recombinant Technology | Class 2 | NWJ |
§878.4493 | Suture, Absorbable, Synthetic, Polyglycolic Acid | Class 2 | GAM |
Class II Special Controls Guidance Document: Surgical Sutures - Guidance for Industry and FDA Staff, Issued June 2003. Class II Special Controls Guidance Document: Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology - Guidance for Industry and FDA Staff, Issue August 2007. |